» Articles » PMID: 7847862

Differentiation of Multiple System Atrophy from Idiopathic Parkinson's Disease Using Proton Magnetic Resonance Spectroscopy

Overview
Journal Ann Neurol
Specialty Neurology
Date 1995 Feb 1
PMID 7847862
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Proton magnetic resonance spectroscopy, localized to the lentiform nucleus, was carried out in 7 patients with the pure or predominantly striatonigral variant (SND) of multiple system atrophy (MSA), 5 patients with the olivopontocerebellar variant of MSA, 9 patients with a clinical diagnosis of idiopathic Parkinson's disease (IPD), and 9 healthy age-matched controls. The MSA group with predominantly striatonigral involvement showed a significant reduction in the N-acetylaspartate (NAA)/creatine ratio (median, 1.19; range, 0.96-2.0; p < 0.02) compared with the NAA/creatine ratio from the control group (median, 1.76; range, 1.61-2.0). In contrast, the IPD group had a normal NAA/creatine ratio (median, 1.82; range, 1.19-2.31; p > 0.05). The NAA/creatine ratio was markedly reduced in 6 of the SND patients and in only 1 IPD patient. The choline/creatine ratio was also significantly lower in the SND group (median, 1.02; range, 0.91-1.23; p < 0.04) compared with the control group (median, 1.22; range, 1.05-1.65). The IPD group showed a normal lentiform choline/creatine ratio (median, 1.13; range, 0.89-1.65; p = 0.25) compared with controls. The olivopontocerebellar group also showed a significant reduction in the NAA/creatine ratio from the lentiform nucleus (median, 1.47; range, 1.22-1.68; p < 0.01) compared with the controls as well as a nonsignificant reduction in the choline/creatine ratio (median, 0.93; range, 0.85-1.27; p < 0.4).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A comparative study of posterior cingulate metabolism in patients with mild cognitive impairment due to Parkinson's disease or Alzheimer's disease.

Huang M, Yu H, Cai X, Zhang Y, Pu W, Gao B Sci Rep. 2023; 13(1):14241.

PMID: 37648724 PMC: 10469183. DOI: 10.1038/s41598-023-41569-5.


Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Heim B, Krismer F, De Marzi R, Seppi K J Neural Transm (Vienna). 2017; 124(8):915-964.

PMID: 28378231 PMC: 5514207. DOI: 10.1007/s00702-017-1717-8.


Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update.

Rizzo G, Zanigni S, De Blasi R, Grasso D, Martino D, Savica R Parkinsons Dis. 2016; 2016:2983638.

PMID: 27774334 PMC: 5059618. DOI: 10.1155/2016/2983638.


Altered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's Disease.

Yu C, Chen M, Lu C, Huang Y, Chen H, Tsai N Oxid Med Cell Longev. 2016; 2016:1810289.

PMID: 27688826 PMC: 5023825. DOI: 10.1155/2016/1810289.


Magnetic resonance imaging markers for early diagnosis of Parkinson's disease.

Marino S, Ciurleo R, Di Lorenzo G, Barresi M, De Salvo S, Giacoppo S Neural Regen Res. 2015; 7(8):611-9.

PMID: 25745453 PMC: 4346987. DOI: 10.3969/j.issn.1673-5374.2012.08.009.